Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

MEDIFAST INC

In a report released on January 13, Luigi Tramontana from Kepler Capital maintained a Hold rating on Banca Mediolanum SpA, with a price target of €...

Banca Mediolanum SpA (BNMDF) Receives a Hold from Kepler Capital

Medaro Mining ( ($TSE:MEDA) ) just unveiled an announcement. Medaro Mining Corp. has entered into an assignment agreement to acquire an option for ...

Medaro Mining Moves to Option Ontario Clay Howells Mineral Property

Kepler Capital analyst Luigi Tramontana maintained a Hold rating on Banca Mediolanum SpA on January 9 and set a price target of €19.00. The company...

Kepler Capital  Keeps Their Hold Rating on Banca Mediolanum SpA (BNMDF)

In a report released on January 7, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Globus Medical, with a price target of $100.00. ...

RBC Capital Reaffirms Their Buy Rating on Globus Medical (GMED)

Jefferies analyst Matthew Taylor reiterated a Buy rating on Globus Medical today and set a price target of $115.00. Taylor covers the Healthcare se...

Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD – Research Report) and Gl...

Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Globus Medical (GMED)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sera Prognostics (SERA – Research Report), Medpace...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sera Prognostics (SERA), Medpace Holdings (MEDP) and LENZ Therapeutics (LENZ)

Barclays analyst Matt Miksic maintained a Buy rating on Globus Medical today and set a price target of $118.00. Miksic covers the Healthcare sector...

Barclays Keeps Their Buy Rating on Globus Medical (GMED)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Globus Medical (GMED – Research Report) and Verrica Pharmaceutica...

Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Verrica Pharmaceuticals (VRCA)

Medaro Mining ( ($TSE:MEDA) ) has issued an update. Medaro Mining Corp. has closed a LIFE private placement offering, issuing 3,742,786 units at $0...

Medaro Mining Raises $524,000 in LIFE Offering to Advance Quebec Lithium Projects

The latest update is out from Medifast ( ($MED) ). On December 30, 2025, Medifast, Inc. agreed that Chief Business Operations Officer and named exe...

Medifast announces leadership changes and CEO succession transition

Analysts have been eager to weigh in on the Healthcare sector with new ratings on InflaRx (IFRX – Research Report) and Globus Medical (GMED – Resea...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MED	$11.82	-0.08%	212.23K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MED	$11.82	-0.1%	212.23K
3
4
5
6

MED

MED

Get MEDIFAST INC Data in Excel

Get MEDIFAST INC Data in Excel